Antecedent Administration of ACEIs or ARBs and Survival After Hospitalization for SARS-CoV-2
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American Heart Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Antecedent Administration of Angiotensin Converting Enzyme Inhibitors or Angiotensin II Receptor Antagonists and Survival After Hospitalization for SARS-CoV-2 (COVID-19)
J Am Heart Assoc 2020 Oct 07;[EPub Ahead of Print], A Palazzuoli, M Mancone, GM De Ferrari, G Forleo, GG Secco, GM Ruocco, F D'Ascenzo, S Monticone, A Paggi, M Vicenzi, AG Palazzo, M Landolina, E Taravelli, G Tavazzi, F Blasi, F Infusino, F Fedele, FG De Rosa, M Emmett, JM Schussler, KM Tecson, PA McCulloughFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.